Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 10

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Mar 14, 2021; 27(10): 976-989
Published online Mar 14, 2021. doi: 10.3748/wjg.v27.i10.976

Full Size Figure Download Figure

Figure 3 Ongoing controversies around use of peptide receptor radionuclide therapy in current practice.

Citation: Lamarca A, Cives M, de Mestier L, Crona J, Spada F, Öberg K, Pavel M, Alonso-Gordoa T. Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3^rd-line treatment. World J Gastroenterol 2021; 27(10): 976-989
URL: https://www.wjgnet.com/1007-9327/full/v27/i10/976.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i10.976

Lamarca A, Cives M, de Mestier L, Crona J, Spada F, Öberg K, Pavel M, Alonso-Gordoa T. Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3^rd-line treatment. World J Gastroenterol 2021; 27(10): 976-989 [PMID: 33776367 DOI: 10.3748/wjg.v27.i10.976]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.